Potentiation by naltrexone of d-amphetamine-induced behavioral suppression and its reversal by clonidine.
D000818:Animals; D003000:Clonidine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects*; D003913:Dextroamphetamine / Q000494:pharmacology*; D004347:Drug Interactions; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000494:pharmacology*; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology
D011954:Receptors, Dopamine; D010868:Pimozide; D009270:Naloxone; D009271:Naltrexone; D003000:Clonidine; D003913:Dextroamphetamine